Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 210 participants.
Also called NCT01914432
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 210 participants
- Sponsor
- Registry
-
NCT01914432
-
- Other papers using this trial's data
- Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01914432. Randomized; quadruple masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2014-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia
- Condition
- Hyperlipidemia
- Condition
- Hypertension
- Intervention (Drug)
- YH16410
- Intervention (Drug)
- Rosuvastatin
- Intervention (Drug)
- Telmisartan
- Intervention (Drug)
- YH16410 placebo
- Intervention (Drug)
- Rosuvastatin placebo
- Intervention (Drug)
- Telmisartan placebo
- Lead sponsor
- Yuhan Corporation
Record details
- Record id
cardio:ct-nct01914432- Content hash
7fb0c53a4db3ae434078e6f496b64957298730430280456582ff4c2d84637777